NCT06337695 VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06332573 Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer Status RECRUITING Phase NA
NCT06332274 tislelizUMaB in canceR Patients With molEcuLar residuaL Disease Status RECRUITING Phase PHASE3
NCT06329531 Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic Status RECRUITING Phase N/A
NCT06329479 A Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Cancer (RALI) Status COMPLETED Phase NA
NCT06327386 The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer Status RECRUITING Phase N/A
NCT06326567 Comprehensive Connected Cancer Care (C4): Intervention Evaluation Status RECRUITING Phase NA
NCT06322992 App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 Status COMPLETED Phase N/A
NCT06321744 Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment Status NOT_YET_RECRUITING Phase NA
NCT06317961 Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools Status RECRUITING Phase N/A
NCT06317389 PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments Status RECRUITING Phase N/A
NCT06315855 F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors) Status RECRUITING Phase NA
NCT06313853 Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision Status RECRUITING Phase NA
NCT06311851 Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT06307249 Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA Status RECRUITING Phase PHASE1